A detailed history of Darwin Global Management, Ltd. transactions in Insmed Inc stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 10,497,277 shares of INSM stock, worth $748 Million. This represents 62.32% of its overall portfolio holdings.

Number of Shares
10,497,277
Previous 3,541,095 196.44%
Holding current value
$748 Million
Previous $237 Million 222.99%
% of portfolio
62.32%
Previous 28.7%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $431 Million - $550 Million
6,956,182 Added 196.44%
10,497,277 $766 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $77.9 Million - $247 Million
3,541,095 New
3,541,095 $237 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.